Best treatments for lymphangioleiomyomatosis
4 products may treat lymphangioleiomyomatosis, spanning FDA drug classes such as kinase inhibitor, mtor inhibitor immunosuppressant. The current highest-rated option is sirolimus. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 4 drugs we list for lymphangioleiomyomatosis, all are available as lower-cost generics, spanning classes such as kinase inhibitor, mtor inhibitor immunosuppressant. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for lymphangioleiomyomatosis — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 66/100 | Prescription | Solution | Kinase Inhibitor | Generic | $49 | View → | |
| 2 | Not yet rated | Prescription | Injectable | Kinase Inhibitor | Generic | $49 | View → | |
| 3 | Not yet rated | Prescription | Topical | Kinase Inhibitor | Generic | $49 | View → | |
| 4 | Not yet rated | Prescription | Solution | Kinase Inhibitor | Generic | $49 | View → |
Narrow by drug class
Explore the class hubs: kinase inhibitor
Full ranking · 4 treatments
sirolimus
Boxed warningPrescriptionFDA-sourced
Sirolimus is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classfyarro
PrescriptionFDA-sourced
Fyarro (Sirolimus) is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classhyftor
PrescriptionFDA-sourced
Hyftor (Sirolimus) is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classrapamune
Boxed warningPrescriptionFDA-sourced
Rapamune (Sirolimus) is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classFrequently asked
- What treats lymphangioleiomyomatosis?
- Our catalog lists 4 products that may treat lymphangioleiomyomatosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is sirolimus.
- What is the best-rated treatment for lymphangioleiomyomatosis?
- By our independent recall-safety rating — not an efficacy measure — sirolimus ranks highest among the products we list for lymphangioleiomyomatosis. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat lymphangioleiomyomatosis?
- Treatments for lymphangioleiomyomatosis span FDA drug classes including kinase inhibitor, mtor inhibitor immunosuppressant. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.